Improving interstitial transport of macromolecules through reduction in cell volume fraction in tumor tissues

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 7, 2012, Pages 1088-1095

  McGuire, Sarah ^a   Yuan, Fan ^a  

^a Duke University   (United States)

Author keywords

Drug delivery; Ethacrynic acid; Hypertonic solution; Mannitol

Indexed keywords

CANCER CELLS; CELL VOLUME FRACTION; CYTOTOXIC AGENTS; DEXTRAN MOLECULES; EX-VIVO; EXPERIMENTAL DATA; EXTRACELLULAR SPACE; MANNITOL; TUMOR TISSUES;

DEXTRAN; DISEASES; DRUG DELIVERY; HISTOLOGY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; TUMORS;

MOLECULES;

DEXTRAN; ETACRYNIC ACID; HYPERTONIC SOLUTION; MANNITOL; NANOPARTICLE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CELL FRACTIONATION; CELL KILLING; CELL VOLUME; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TRANSPORT; EX VIVO STUDY; FIBROSARCOMA; INTERSTITIUM; MACROMOLECULE; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; MOLECULE; NONHUMAN; PARTICLE SIZE; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL TRANSPORT; CELL SIZE; CYTOTOXINS; DEXTRANS; DRUG DELIVERY SYSTEMS; ETHACRYNIC ACID; EXTRACELLULAR FLUID; FIBROSARCOMA; MANNITOL; RATS; SKIN NEOPLASMS;

RATTUS;

EID: 84866517125     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.12.009     Document Type: Article

References (39)

1. Jain R.K. Delivery of molecular and cellular medicine to solid tumors. Microcirculation 1997, 4:1-23.
2. Jain R.K. The next frontier of molecular medicine - delivery of therapeutics. Nat Med 1998, 4:655-657.
3. Henshaw J.W., Yuan F. Field distribution and DNA transport in solid tumors during electric field-mediated gene delivery. J Pharm Sci 2008, 97:691-711.
4. Wang Y., Yuan F. Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement. Ann Biomed Eng 2006, 34:114-127.
5. Yuan F. Physiological Barriers to Drug Transport. The Biomedical Engineering Handbook 2012, CRC Press, Boca Raton, FL. 4th ed. J.D. Bronzino, D.R. Peterson (Eds.).
6. Juweid M., Neumann R., Paik C., Perez-Bacete M.J., Sato J., van Osdol W., et al. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res 1992, 52:5144-5153.
7. Milenic D.E., Yokota T., Filpula D.R., Finkelman M.A., Dodd S.W., Wood J.F., et al. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res 1991, 51:6363-6371.
8. Yuan F. Transvascular drug delivery in solid tumors. Semin Rad Oncol 1998, 8:164-175.
9. Dang W., Colvin O.M., Brem H., Saltzman W.M. Covalent coupling of methotrexate to dextran enhances the penetration of cytotoxicity into a tissue-like matrix. Cancer Res 1994, 54:1729-1735.
10. Fung L.K., Saltzman W.M. Polymeric implants for cancer chemotherapy. Adv Drug Delivery Rev 1997, 26:209-230.
11. Shea L.D., Smiley E., Bonadio J., Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat Biotech 1999, 17:551-554.
12. Kim J.H., Lee Y.S., Kim H., Huang J.H., Yoon A.R., Yun C.O. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J Natl Cancer Inst 2006, 98:1482-1493.
13. Henshaw J., Mossop B., Yuan F. Relaxin treatment of solid tumors: effects on electric field-mediated gene delivery. Mol Cancer Ther 2008, 7:2566-2573.
14. Yuan F., Krol A., Tong S. Available space and extracellular transport of macromolecules: effects of pore size and connectedness. Ann Biomed Eng 2001, 29:1150-1158.
15. Griffon-Etienne G., Boucher Y., Brekken C., Suit H.D., Jain R.K. Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res 1999, 59:3776-3782.
16. Lu D., Wientjes M.G., Lu Z., Au J.L. Tumor priming enhances delivery and efficacy of nanomedicines. J Pharmacol Exp Ther 2007, 322:80-88.
17. Minchinton A.I., Tannock I.F. Drug penetration in solid tumours. Nat Rev Cancer 2006, 6:583-592.
18. Henshaw J., Mossop B., Yuan F. Enhancement of electric field-mediated gene delivery through pretreatment of tumors with a hyperosmotic mannitol solution. Cancer Gene Ther 2011, 18:26-33.
19. Erickson-Lamy K., Schroeder A., Epstein D.L. Ethacrynic acid induces reversible shape and cytoskeletal changes in cultured cells. Invest Ophthalmol Vis Sci 1992, 33:2631-2640.
20. Xu S., Roychowdhury S., Gaskin F., Epstein D.L. Ethacrynic acid inhibition of microtubule assembly in vitro. Arch Biochem Biophys 1992, 296:462-467.
21. Gills J.P., Roberts B.C., Epstein D.L. Microtubule disruption leads to cellular contraction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 1998, 39:653-658.
22. O'Brien E.T., Kinch M., Harding T.W., Epstein D.L. A mechanism for trabecular meshwork cell retraction: ethacrynic acid initiates the dephosphorylation of focal adhesion proteins. Exp Eye Res 1997, 65:471-483.
23. Rao P.V., Shimazaki A., Ichikawa M., Alvarado J.A., Epstein D.L. Effects of novel ethacrynic acid derivatives on human trabecular meshwork cell shape, actin cytoskeletal organization, and transcellular fluid flow. Biol Pharm Bull 2005, 28:2189-2196.
24. Zhang X.Y., Luck J., Dewhirst M.W., Yuan F. Interstitial hydraulic conductivity in a fibrosarcoma. Am J Physiol 2000, 279:H2726-H2734.
25. McGuire S., Yuan F. Quantitative analysis of intratumoral infusion of color molecules. Am J Physiol 2001, 281:H715-H721.
26. Armstrong J.K., Wenby R.B., Meiselman H.J., Fisher T.C. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys J 2004, 87:4259-4270.
27. Krol A., Maresca J., Dewhirst M.W., Yuan F. Available volume fraction of macromolecules in a fibrosarcoma: Implications for drug delivery. Cancer Res 1999, 59:4136-4141.
28. Truskey G.A., Yuan F., Katz D.F. Transport Phenomena Biological Systems 2009, Pearson Education, Inc., Upper Saddle River (N.J.). 2nd ed.
29. Krol A., Dewhirst M.W., Yuan F. Effects of cell damage and glycosaminoglycan degradation on available extravascular space of different dextrans in a rat fibrosarcoma. Int J Hyperthermia 2003, 19:154-164.
30. Sarin R., Murthy V. Medical decompressive therapy for primary and metastatic intracranial tumours. Lancet Neurol 2003, 2:357-365.
31. Schrot R.J., Muizelaar J.P. Mannitol in acute traumatic brain injury. Lancet 2002, 359:1633-1634.
32. Lameire N.H., De Vriese A.S., Vanholder R. Prevention and nondialytic treatment of acute renal failure. Curr Opin Crit Care 2003, 9:481-490.
33. Guillaume D.J., Doolittle N.D., Gahramanov S., Hedrick N.A., Delashaw J.B., Neuwelt E.A. Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study. Neurosurgery 2010, 66:48-58. [discussion 58].
34. Boockvar J.A., Tsiouris A.J., Hofstetter C.P., Kovanlikaya I., Fralin S., Kesavabhotla K., et al. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article. J Neurosurg 2011, 114:624-632.
35. Mastakov M.Y., Baer K., Xu R., Fitzsimons H., During M.J. Combined injection of rAAV with mannitol enhances gene expression in the rat brain. Mol Ther 2001, 3:225-232.
36. Bourgoin C., Emiliani C., Kremer E.J., Gelot A., Tancini B., Gravel R.A., et al. Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol. Gene Ther 2003, 10:1841-1849.
37. Lin C.W. Drug Delivery to the eye for treatment of primary open-angle glaucoma 2006, Department of Biomedical Engineering, Ph.D. Dissertation. Duke University, Durham, NC.
38. Jang S.H., Wientjes M.G., Au J.L. Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. J Pharmacol Exp Ther 2001, 296:1035-1042.
39. Kuh H.J., Jang S.H., Wientjes M.G., Weaver J.R., Au J.L. Determinants of paclitaxel penetration and accumulation in human solid tumor. JPharmacol Exp Ther 1999, 290:871-880.